Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2026 | Q4 | $2.3M | -- | -- | -- | -- |
| 11/12/2025 | Q3 | -- | $2.2M | $0.56 | -- | -- |
| 08/14/2025 | Q2 | -- | $1.7M | -$60.98 | -- | -- |
| 03/31/2025 | Q1 | $2.5M | $1.9M | -$0.69 | -- | -- |
| 12/31/2024 | Q4 | $2.5M | $2.3M | -$18.31 | -- | -- |
| 09/30/2024 | Q3 | $2.4M | $2.4M | $1.74 | -- | -- |
| 06/30/2024 | Q2 | $2M | $2.2M | -$18.86 | -- | -- |
| 03/31/2024 | Q1 | $2M | $1.9M | -$21.10 | -- | -- |
| 12/31/2023 | Q4 | $2.6M | $2.6M | -$78.39 | -- | -- |
| 09/30/2023 | Q3 | $2.3M | $2.4M | -$63.28 | -- | -- |
| 06/30/2023 | Q2 | $2.2M | $2.1M | -$127.69 | -- | -- |
| 03/31/2023 | Q1 | -- | $1.8M | -$201.58 | -- | -- |
| 12/31/2022 | Q4 | -- | $2.3M | -$175.09 | -- | -- |
| 09/30/2022 | Q3 | -- | $2.1M | -$1,285.34 | -- | -- |
| 08/09/2022 | Q2 | -- | $2.2M | -$1,423.52 | -- | -- |
| 05/11/2022 | Q1 | -- | $1.9M | -$1,485.61 | -- | -- |
| 03/02/2022 | Q4 | -- | $1.6M | -$1,446.10 | -- | -- |
| 11/10/2021 | Q3 | -- | $1.9M | -$2,599.59 | -- | -- |
| 08/09/2021 | Q2 | -- | $2.5M | -$2,534.98 | -- | -- |
| 05/11/2021 | Q1 | -- | $1.9M | -$4,365.87 | -- | -- |
| 03/02/2021 | Q4 | -- | $2M | -$3,947.72 | -- | -- |
| 11/10/2020 | Q3 | -- | $1.9M | -$7,565.25 | -- | -- |
| 08/04/2020 | Q2 | -- | $1.9M | -$10,859.10 | -- | -- |
| 03/31/2020 | Q1 | -- | $1.6M | -$39,320.40 | -- | -- |
| 12/31/2019 | Q4 | -- | $1.4M | -$117,111.75 | -- | -- |
| 09/30/2019 | Q3 | -- | $1.3M | -$178,928.40 | -- | -- |
| 06/30/2019 | Q2 | -- | $1.7M | -$202,679.40 | -- | -- |
| 03/31/2019 | Q1 | -- | $1.2M | -$1,204,565.25 | -- | -- |
| 12/31/2018 | Q4 | -- | $1.5M | -$877,957.50 | -- | -- |
| 09/30/2018 | Q3 | -- | $1.4M | -$892,260.60 | -- | -- |
| 06/30/2018 | Q2 | -- | $1.1M | -$1,367,614.50 | -- | -- |
| 03/31/2018 | Q1 | -- | $1M | -$1,587,791.10 | -- | -- |
| 12/31/2017 | Q4 | -- | $831K | -$6,610,825.21 | -- | -- |
| 10/31/2017 | Q3 | -- | $957K | -$6,685,560.01 | -- | -- |
| 08/08/2017 | Q2 | -- | $864K | -$9,726,108.01 | -- | -- |
| 03/31/2017 | Q1 | -- | $901K | -$17,502,114.02 | -- | -- |
| 12/31/2016 | Q4 | -- | $746K | -$117,464,760.84 | -- | -- |
| 09/30/2016 | Q3 | -- | $543K | -$172,960,201.23 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$202,860,001.44 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$229,320,001.63 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
Nuwellis, Inc. reported $2.2M worth of top line sales in its most recent quarter.
Nuwellis, Inc. announced earnings per share of $0.56 which represents a beat of analyst forecast a -- per share.
Nuwellis, Inc. reported $1.4M that represents $1.73 per share over the last quarter.
Nuwellis, Inc.'s earnings are forecast to grow from -$336.19 per share to -- per share next year representing an increase of --.
Nuwellis, Inc.'s next earnings date is March 10, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.